192 related articles for article (PubMed ID: 20567502)
1. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions.
de Jong EP; Xie H; Onsongo G; Stone MD; Chen XB; Kooren JA; Refsland EW; Griffin RJ; Ondrey FG; Wu B; Le CT; Rhodus NL; Carlis JV; Griffin TJ
PLoS One; 2010 Jun; 5(6):e11148. PubMed ID: 20567502
[TBL] [Abstract][Full Text] [Related]
2. Salivary biomarkers for oral cancer and pre-cancer screening: a review.
Kaur J; Jacobs R; Huang Y; Salvo N; Politis C
Clin Oral Investig; 2018 Mar; 22(2):633-640. PubMed ID: 29344805
[TBL] [Abstract][Full Text] [Related]
3. Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.
Ploypetch S; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Krobthong S; Suriyaphol G
PLoS One; 2019; 14(7):e0219390. PubMed ID: 31318878
[TBL] [Abstract][Full Text] [Related]
4. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
Kaur J; Politis C; Jacobs R
Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
[TBL] [Abstract][Full Text] [Related]
5. Review Insights on Salivary Proteomics Biomarkers in Oral Cancer Detection and Diagnosis.
Umapathy VR; Natarajan PM; Swamikannu B
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446943
[TBL] [Abstract][Full Text] [Related]
6. Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry.
Xie H; Onsongo G; Popko J; de Jong EP; Cao J; Carlis JV; Griffin RJ; Rhodus NL; Griffin TJ
Mol Cell Proteomics; 2008 Mar; 7(3):486-98. PubMed ID: 18045803
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Salivary and Serum Alkaline Phosphates Level and Lactate Dehydrogenase Levels in Patients with Tobacco Related Oral Lesions with Healthy Subjects - A Step Towards Early Diagnosis.
Goyal G
Asian Pac J Cancer Prev; 2020 Apr; 21(4):983-991. PubMed ID: 32334459
[TBL] [Abstract][Full Text] [Related]
8. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker.
Yang Y; Rhodus NL; Ondrey FG; Wuertz BR; Chen X; Zhu Y; Griffin TJ
PLoS One; 2014; 9(4):e95389. PubMed ID: 24748380
[TBL] [Abstract][Full Text] [Related]
10. A Review on Salivary Proteomics for Oral Cancer Screening.
Li Q; Ouyang X; Chen J; Zhang P; Feng Y
Curr Issues Mol Biol; 2020; 37():47-56. PubMed ID: 31950916
[TBL] [Abstract][Full Text] [Related]
11. Advances in the Diagnosis, Monitoring, and Progression of Oral Cancer through Saliva: An Update.
Rodríguez-Molinero J; Del Carmen Migueláñez-Medrán B; Delgado-Somolinos E; Carreras-Presas CM; López-Sánchez AF
Biomed Res Int; 2022; 2022():2739869. PubMed ID: 36330456
[TBL] [Abstract][Full Text] [Related]
12. Salivary β2-microglobulin levels in patients with erosive oral lichen planus and squamous cell carcinoma.
Nosratzehi F; Nosratzehi T; Alijani E; Rad SS
BMC Res Notes; 2020 Jun; 13(1):294. PubMed ID: 32552881
[TBL] [Abstract][Full Text] [Related]
13. Role of Salivary Biomarkers in Oral Cancer Detection.
Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
[TBL] [Abstract][Full Text] [Related]
14. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas.
Shan J; Sun Z; Yang J; Xu J; Shi W; Wu Y; Fan Y; Li H
Oral Dis; 2019 Jan; 25(1):97-107. PubMed ID: 30169911
[TBL] [Abstract][Full Text] [Related]
15. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
[TBL] [Abstract][Full Text] [Related]
16. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery.
Xiao H; Langerman A; Zhang Y; Khalid O; Hu S; Cao CX; Lingen MW; Wong DTW
Oral Oncol; 2015 Nov; 51(11):1011-1019. PubMed ID: 26321370
[TBL] [Abstract][Full Text] [Related]
18. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
Ghallab NA; Shaker OG
Clin Oral Investig; 2017 Apr; 21(3):937-947. PubMed ID: 27161218
[TBL] [Abstract][Full Text] [Related]
19. Salivary N-glycosylation as a biomarker of oral cancer: A pilot study.
Sinevici N; Mittermayr S; Davey GP; Bones J; O'Sullivan J
Glycobiology; 2019 Sep; 29(10):726-734. PubMed ID: 31245822
[TBL] [Abstract][Full Text] [Related]
20. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry.
Hu S; Yu T; Xie Y; Yang Y; Li Y; Zhou X; Tsung S; Loo RR; Loo JR; Wong DT
Cancer Genomics Proteomics; 2007; 4(2):55-64. PubMed ID: 17804867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
